Medolone

Aciclovir, the active ingredient in Medolone, is an antiviral presented as an injection solution for intravenous use. It treats herpes simplex virus infections, varicella‑zoster virus infections, herpes encephalitis, and in some settings cytomegalovirus infections, primarily in hospitalized patients.

GNH USA supplies Medolone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Medolone, an antiviral agent, is employed for infections caused by herpes viruses.

Herpes simplex virus infection: reduces viral replication and accelerates lesion healing. Varicella‑zoster virus infection: limits viral spread and eases symptoms of shingles or severe chickenpox. Herpes encephalitis: suppresses viral activity in the central nervous system to improve outcomes. Cytomegalovirus infection (off‑label): may be used in selected severe cases where other therapies are unsuitable.

Common Side Effects: - Headache: mild to moderate discomfort during or after infusion. - Nausea or vomiting: gastrointestinal upset that may resolve with anti‑emetics. - Fever: transient rise in body temperature. - Injection site reactions: redness, pain, or swelling at the infusion site. - Rash: mild skin eruptions.

Serious or Rare Side Effects: - Nephrotoxicity: impaired kidney function, especially with high doses or dehydration. - Neurotoxicity: confusion, hallucinations, seizures in susceptible patients. - Severe allergic reactions: anaphylaxis, angioedema requiring immediate medical attention. - Thrombophlebitis: inflammation of veins at the infusion site. - Hemolytic anemia: rare destruction of red blood cells.

Before initiating therapy, consider the following precautions.

Renal function: adjust dosing in patients with impaired kidney function. Hydration: ensure adequate fluid intake to reduce risk of nephrotoxicity. Pregnancy: use only if the potential benefit justifies the potential risk. Concomitant nephrotoxic drugs: monitor closely when given with aminoglycosides or amphotericin B. Infusion rate: administer over the recommended period to minimize adverse reactions. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Aciclovir may interact with several medicines; monitor as indicated.

Major Interactions (Avoid): - Probenecid: decreases renal clearance, raising aciclovir plasma levels. - Concurrent nephrotoxic agents (e.g., aminoglycosides, amphotericin B): increase risk of kidney injury. - Cimetidine: may elevate serum concentrations of aciclovir.

Moderate Interactions (Monitor Closely): - NSAIDs: can affect renal function when combined with aciclovir. - Loop diuretics: may potentiate nephrotoxic effects. - Other antivirals (e.g., ganciclovir): additive toxicity potential.